Bishal Gyawali, Associate Professor at Queen’s University, shared on X:
“Incredibly proud of this new paper in ESMO Open involving several of BG Lab members (Javier David Benitez Fuentes, Laure-Anne Teuwen, Elen Baloyan and myself) in collaboration with colleagues from EORTC
(Winette Van Der Graaf and Dr. Denis Lacombe).
In this open access paper, we discuss why access to clinical trials is an important equity metric but also highlight how ‘not all clinical trials are created equal‘.
Just like when we argue for access to cancer drugs, it means access to meaningful drugs not just any drugs. Similarly, when we argue for access to clinical trials, it does not mean access to any trials.”
Title: Access to cancer clinical trials in Europe: when trial availability does not match patient need
Authors: A.D. Lázaro Sánchez, J.D. Benitez-Fuentes, L.-A. Teuwen, E. Baloyan, J.L. Alonso Romero, A. Rodriguez-Lescure, D. Lacombe, W.T.A. van der Graaf, B. Gyawali
Read the full article.
You can also read:
A Unified Framework for Pre-Screening and Screening Tools in Oncology Clinical Trials 2026
